• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Italy Poultry Vaccines Market

    ID: MRFR/Pharma/48781-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Italy Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Italy Poultry Vaccines Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Italy Poultry Vaccines Market Summary

    The Italy Poultry Vaccines market is projected to grow from 157.5 million USD in 2024 to 281.8 million USD by 2035.

    Key Market Trends & Highlights

    Italy Poultry Vaccines Key Trends and Highlights

    • The market valuation is expected to reach 281.8 million USD by the year 2035.
    • A compound annual growth rate of 5.43 percent is anticipated from 2025 to 2035.
    • In 2024, the market is valued at 157.5 million USD, indicating a robust growth trajectory.
    • Growing adoption of advanced vaccination technologies due to increasing poultry disease outbreaks is a major market driver.

    Market Size & Forecast

    2024 Market Size 157.5 (USD Million)
    2035 Market Size 281.8 (USD Million)
    CAGR (2025-2035) 5.43%

    Major Players

    Hipra, Phibro Animal Health, Virbac, Merial (now part of Boehringer Ingelheim), Ceva Santé Animale, Lohmann Animal Health, Heska Corporation, Zoetis, Vetoquinol, Elanco Animal Health, Kemin Industries, Merck Animal Health, Agrovet, Boehringer Ingelheim

    Italy Poultry Vaccines Market Trends

    The Italy Poultry Vaccines Market is witnessing significant trends driven by the growing awareness of animal health and biosecurity among poultry farmers. The Italian government has implemented measures to promote animal health, emphasizing vaccination as a crucial component in preventing the spread of poultry diseases. This initiative is a response to the rising incidences of avian influenza and other infectious diseases affecting poultry, compelling farmers to adopt vaccination as a key practice. Additionally, the demand for vaccines tailored to specific strains of poultry diseases is increasing as Italy's poultry population expands.

    There are substantial opportunities to be explored within the Italy poultry vaccines sector. With a strong agricultural base, Italy has the potential to innovate vaccine development, focusing on region-specific poultry health challenges. Furthermore, the integration of advanced technologies such as recombinant vaccines and DNA vaccines is expected to gain traction, presenting opportunities for domestic companies to enhance their product offerings and cater to evolving market needs. Recent trends indicate a shift towards more sustainable and environmentally friendly practices in vaccine development.

    The Italian poultry sector is increasingly aligning with European Union standards, which emphasize the importance of reducing antibiotic use through effective vaccination strategies. This trend reflects a broader commitment to improving animal welfare and ensuring food safety. Overall, the Italy Poultry Vaccines Market is adapting to meet the demands of a modern agricultural landscape, driven by government initiatives and a proactive approach from poultry farmers toward health management.

    Italy Poultry Vaccines Market Drivers

    Market Segment Insights

    Poultry Vaccines Market Type Insights

    The Italy Poultry Vaccines Market is a vital component of the country's agricultural landscape, focused on enhancing poultry health and production efficiency through various types of vaccines. Among the key types within this market, Live Attenuated Vaccines are prominent due to their ability to induce strong immune responses and provide long-lasting protection against diseases. These vaccines are often considered vital for controlling outbreaks in poultry populations, which is significant given Italy's robust poultry industry.

    Inactivated Vaccines also play an essential role in this market, providing safe and effective immunization options particularly for vulnerable flocks, where live vaccines may pose risks. These vaccines are critical in maintaining herd immunity, especially in large-scale production settings.

    Subunit Vaccines are gaining traction in the Italy Poultry Vaccines Market due to their safety profile and efficacy in eliciting immune responses while minimizing side effects. By targeting specific antigens, these vaccines are pivotal in managing complex diseases affecting poultry.

    Additionally, DNA Vaccines are on the rise, representing a novel approach in immunization strategies that shows promise due to their ease of use and capability of inducing robust immune responses. They are especially important in addressing emerging poultry diseases, providing an innovative solution for the industry.

    Each type of vaccine contributes uniquely to the overall health of poultry populations in Italy, and their development reflects a response to the unique challenges faced by the agricultural sector in the region. As the demand for poultry products continues to grow, the relevance of these different types of vaccines becomes even more pronounced in ensuring sustainable poultry farming practices and improving overall market health. Thus, investments in Research and Development will be essential to accelerate advancements in these vaccine types for the Italy Poultry Vaccines Market.

    Poultry Vaccines Market Species Insights

    The Italy Poultry Vaccines Market is segmented by Species, capturing a diverse range of poultry categories including Broilers, Layers, Turkeys, and Others. In Italy, Broilers are critical to the poultry industry, representing a substantial portion of meat production and consumption. This raises the necessity for effective vaccines to ensure their health and mitigate disease outbreaks, which directly influence poultry yield and food security. Layers, on the other hand, are vital for egg production, driving advancements in vaccination protocols to enhance egg quality and sustainability practices.

    Turkeys are also significant, especially in the festive season, necessitating tailored vaccination strategies to meet market demand and health standards. The category of Others encompasses various poultry types, contributing to niche markets and requiring specialized vaccine solutions. Overall, the increasing emphasis on poultry health, biosecurity measures, and rising consumer demand for poultry products in Italy highlights the importance of Species segmentation in shaping the market growth and trends within the Italy Poultry Vaccines Market.

    Poultry Vaccines Market Administration Route Insights

    The Administration Route segment of the Italy Poultry Vaccines Market plays a pivotal role in ensuring effective vaccination strategies for poultry health, addressing the growing demand for disease prevention in the avian industry. Various methods such as Intramuscular, Subcutaneous, Oral, and Inhalation routes are employed to deliver vaccines, each possessing distinct advantages. Intramuscular administration is widely recognized for its ability to elicit a robust immune response, making it a preferred choice among poultry farmers. The Subcutaneous route offers ease of administration and minimal discomfort, appealing to smaller poultry operations.

    Conversely, Oral vaccination provides a non-invasive approach, allowing for easier mass vaccination, particularly in larger flocks. Inhalation methods are gaining traction due to their efficiency in targeting respiratory pathogens, which are a significant concern in poultry health management. The increasing focus on biosecurity and disease outbreak prevention in Italy further underscores the importance of these Administration Routes, as substantial investments are being made to enhance vaccination programs.

    The intertwining of these methodologies within Italy's poultry industry reflects not only the need for effective disease management but also opens up opportunities for innovation in vaccine delivery. As Italy continues to prioritize animal health and welfare, the Administration Route segment will remain critical to addressing the challenges and demands of poultry farmers.

    Poultry Vaccines Market Disease Targeted Insights

    The Disease Targeted segment within the Italy Poultry Vaccines Market plays a critical role in ensuring the health of poultry stocks and maintaining the productivity of the industry. Newcastle Disease, known for its high mortality rates among affected birds, remains a significant focus, as vaccines for this disease contribute to substantial protective measures for poultry farmers. Infectious Bursal Disease is another prominent concern; vaccines target this viral infection to promote optimal growth and performance in young birds.

    Additionally, the threat of Avian Influenza necessitates robust vaccination strategies, as outbreaks can severely impact both the poultry industry and public health, leading to enhanced biosecurity measures. Marek's Disease also represents a dominating challenge within the market, highlighting the need for effective vaccination to manage this highly contagious and potentially fatal disease. The increasing awareness of poultry health and the desire for sustainable farming practices in Italy provide ample opportunities for growth within this segment as poultry vaccinations continue to evolve in response to emerging challenges.

    Overall, the emphasis on disease prevention through targeted vaccines underscores the vital nature of this segment in bolstering the resilience of Italy's poultry industry.

    Get more detailed insights about Italy Poultry Vaccines Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The Italy Poultry Vaccines Market is characterized by an increasingly competitive landscape driven by a growing emphasis on poultry health and a rising awareness of disease prevention among avian livestock. This market is evolving with continuous advancements in vaccine technology and the strategic initiatives taken by various companies to innovate and enhance their product offerings. The competitive dynamics are shaped by factors such as changing regulations, consumer preferences, and the need for effective disease management solutions in poultry farming.

    Additionally, the collaboration between academia and industry players is fostering a more research-oriented environment that aims to tackle complex poultry health issues while ensuring compliance with stringent regulatory standards. As the market progresses, businesses are focusing on the incorporation of novel delivery methods and comprehensive vaccine portfolios to capture a larger market share.

    Hipra has established a strong foothold in the Italy Poultry Vaccines Market, positioning itself as a key player with a diverse range of veterinary products specifically tailored for poultry. The company’s commitment to innovation and its focus on research and development has allowed it to introduce effective vaccines that cater to a variety of avian diseases, thereby enhancing its reputation among poultry producers. Hipra's strategic approach includes collaboration with local veterinarians and educational institutions to ensure that their solutions meet the evolving needs of poultry health in Italy.

    The company’s strengths lie in its specialized knowledge in the field, a robust distribution network, and the ability to respond swiftly to market demands, which collectively bolster its competitive advantage in the region.

    Phibro Animal Health has a notable presence in the Italy Poultry Vaccines Market, known for its comprehensive portfolio that includes vaccines, nutritional products, and pharmaceuticals aimed at improving animal health and performance. The company’s commitment to developing effective vaccines against common poultry ailments is evident in their tailored solutions which address local health challenges. With a strong emphasis on customer relationships, Phibro ensures reliable support and service to poultry producers throughout Italy.

    The company has a history of strategic mergers and acquisitions that have enabled it to expand its market reach and enhance its product offerings, solidifying its position in the competitive landscape. Additionally, Phibro’s extensive research and development capabilities contribute to its strength, allowing the company to remain at the forefront of innovations that cater specifically to the needs of the Italian poultry sector.

    Key Companies in the Italy Poultry Vaccines Market market include

    Industry Developments

    In recent developments within the Italy Poultry Vaccines Market, companies like Hipra and Zoetis have been actively enhancing their vaccine portfolios to address emerging poultry diseases, notably Avian Influenza and Newcastle Disease. In February 2023, Merck Animal Health launched a new vaccine formulation aimed at boosting immunity in poultry, which has triggered increased interest from local poultry farmers. Additionally, Phibro Animal Health announced advancements in their vaccine technology in March 2023, optimizing vaccine efficacy and safety for bird populations.

    Current market dynamics indicate that the growth valuation of companies such as Elanco Animal Health and Virbac has significantly impacted the vaccination strategies employed by Italian poultry producers, leading to a higher adoption rate of vaccination protocols among poultry farms.

    A notable merger took place in July 2023 when Boehringer Ingelheim acquired a smaller biotechnology firm focused on avian vaccines, bolstering their research capabilities in Italy. Over the past two years, the market has seen heightened regulatory support from Italian health authorities, further improving vaccine accessibility and distribution mechanisms across the nation, which has been crucial during pandemic periods. The emphasis on biosecurity and vaccination reflects an ongoing commitment to enhancing animal health within the Italian poultry sector.

    Market Segmentation

    Poultry Vaccines Market Type Outlook

    • Live Attenuated Vaccines
    • Inactivated Vaccines
    • Subunit Vaccines
    • DNA Vaccines

    Poultry Vaccines Market Species Outlook

    • Broilers
    • Layers
    • Turkeys
    • Others

    Poultry Vaccines Market Disease Targeted Outlook

    • Newcastle Disease
    • Infectious Bursal Disease
    • Avian Influenza
    • Marek's Disease

    Poultry Vaccines Market Administration Route Outlook

    • Intramuscular
    • Subcutaneous
    • Oral
    • Inhalation

    Report Scope

     
    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 157.5(USD Million)
    MARKET SIZE 2024 164.5(USD Million)
    MARKET SIZE 2035 281.8(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 5.015% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED Hipra, Phibro Animal Health, Virbac, Merial, Ceva Santé Animale, Lohmann Animal Health, Heska Corporation, Zoetis, Vetoquinol, Elanco Animal Health, Kemin Industries, Merck Animal Health, Agrovet, Boehringer Ingelheim
    SEGMENTS COVERED Type, Species, Administration Route, Disease Targeted
    KEY MARKET OPPORTUNITIES Increasing demand for poultry health, Rising awareness of vaccination benefits, Expansion of poultry farming practices, Government support for vaccination programs, Technological advancements in vaccine development
    KEY MARKET DYNAMICS Increasing poultry production demands, Stringent regulatory standards, Rising awareness of animal health, Technological advancements in vaccines, Growth in export opportunities
    COUNTRIES COVERED Italy

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market size of the Italy Poultry Vaccines Market in 2024?

    The Italy Poultry Vaccines Market is expected to be valued at 164.5 million USD in 2024.

    What will the market size of the Italy Poultry Vaccines Market be by 2035?

    By 2035, the market size is projected to reach 281.8 million USD.

    What is the expected CAGR for the Italy Poultry Vaccines Market from 2025 to 2035?

    The anticipated compound annual growth rate (CAGR) for the market is 5.015 percent during the forecast period.

    Which type of vaccines will dominate the Italy Poultry Vaccines Market in 2035?

    In 2035, live attenuated vaccines are expected to dominate the market with a valuation of 86.0 million USD.

    What value will inactivated vaccines hold in the Italy Poultry Vaccines Market by 2035?

    Inactivated vaccines are projected to have a market value of 68.0 million USD by 2035.

    Who are the key players in the Italy Poultry Vaccines Market?

    Major players include Hipra, Phibro Animal Health, Virbac, Merial, Ceva Santé Animale, and others.

    What is the market value for subunit vaccines in the year 2024?

    Subunit vaccines are valued at 35.0 million USD in 2024.

    How much will DNA vaccines contribute to the Italy Poultry Vaccines Market by 2035?

    By 2035, DNA vaccines are expected to contribute 67.8 million USD to the market.

    What are the main growth drivers for the Italy Poultry Vaccines Market?

    The market growth is driven by increasing poultry farming activities and rising awareness of livestock health.

    What challenges does the Italy Poultry Vaccines Market face?

    Challenges include regulatory hurdles, competition among manufacturers, and the need for innovation in vaccine development.

    1. EXECUTIVE
    2. SUMMARY
    3. Market Overview
    4. Key Findings
    5. Market Segmentation
    6. Competitive Landscape
    7. Challenges and Opportunities
    8. Future Outlook
    9. MARKET INTRODUCTION
    10. Definition
    11. Scope of the study
    12. Research Objective
    13. Assumption
    14. Limitations
    15. RESEARCH
    16. METHODOLOGY
    17. Overview
    18. Data
    19. Mining
    20. Secondary Research
    21. Primary
    22. Research
    23. Primary Interviews and Information Gathering
    24. Process
    25. Breakdown of Primary Respondents
    26. Forecasting
    27. Model
    28. Market Size Estimation
    29. Bottom-Up
    30. Approach
    31. Top-Down Approach
    32. Data
    33. Triangulation
    34. Validation
    35. MARKET
    36. DYNAMICS
    37. Overview
    38. Drivers
    39. Restraints
    40. Opportunities
    41. MARKET FACTOR ANALYSIS
    42. Value chain Analysis
    43. Porter's
    44. Five Forces Analysis
    45. Bargaining Power of Suppliers
    46. Bargaining
    47. Power of Buyers
    48. Threat of New Entrants
    49. Threat
    50. of Substitutes
    51. Intensity of Rivalry
    52. COVID-19
    53. Impact Analysis
    54. Market Impact Analysis
    55. Regional
    56. Impact
    57. Opportunity and Threat Analysis
    58. Italy
    59. Poultry Vaccines Market, BY Type (USD Million)
    60. Live
    61. Attenuated Vaccines
    62. Inactivated Vaccines
    63. Subunit
    64. Vaccines
    65. DNA Vaccines
    66. Italy
    67. Poultry Vaccines Market, BY Species (USD Million)
    68. Broilers
    69. Layers
    70. Turkeys
    71. Others
    72. Italy
    73. Poultry Vaccines Market, BY Administration Route (USD Million)
    74. Intramuscular
    75. Subcutaneous
    76. Oral
    77. Inhalation
    78. Italy
    79. Poultry Vaccines Market, BY Disease Targeted (USD Million)
    80. Newcastle
    81. Disease
    82. Infectious Bursal Disease
    83. Avian
    84. Influenza
    85. Marek's Disease
    86. Competitive Landscape
    87. Overview
    88. Competitive
    89. Analysis
    90. Market share Analysis
    91. Major
    92. Growth Strategy in the Poultry Vaccines Market
    93. Competitive
    94. Benchmarking
    95. Leading Players in Terms of Number of Developments
    96. in the Poultry Vaccines Market
    97. Key developments and growth
    98. strategies
    99. New Product Launch/Service Deployment
    100. Merger
    101. & Acquisitions
    102. Joint Ventures
    103. Major
    104. Players Financial Matrix
    105. Sales and Operating Income
    106. Major
    107. Players R&D Expenditure. 2023
    108. Company
    109. Profiles
    110. Hipra
    111. Financial
    112. Overview
    113. Products Offered
    114. Key
    115. Developments
    116. SWOT Analysis
    117. Key
    118. Strategies
    119. Phibro Animal Health
    120. Financial
    121. Overview
    122. Products Offered
    123. Key
    124. Developments
    125. SWOT Analysis
    126. Key
    127. Strategies
    128. Virbac
    129. Financial
    130. Overview
    131. Products Offered
    132. Key
    133. Developments
    134. SWOT Analysis
    135. Key
    136. Strategies
    137. Merial
    138. Financial
    139. Overview
    140. Products Offered
    141. Key
    142. Developments
    143. SWOT Analysis
    144. Key
    145. Strategies
    146. Ceva Santé Animale
    147. Financial
    148. Overview
    149. Products Offered
    150. Key
    151. Developments
    152. SWOT Analysis
    153. Key
    154. Strategies
    155. Lohmann Animal Health
    156. Financial
    157. Overview
    158. Products Offered
    159. Key
    160. Developments
    161. SWOT Analysis
    162. Key
    163. Strategies
    164. Heska Corporation
    165. Financial
    166. Overview
    167. Products Offered
    168. Key
    169. Developments
    170. SWOT Analysis
    171. Key
    172. Strategies
    173. Zoetis
    174. Financial
    175. Overview
    176. Products Offered
    177. Key
    178. Developments
    179. SWOT Analysis
    180. Key
    181. Strategies
    182. Vetoquinol
    183. Financial
    184. Overview
    185. Products Offered
    186. Key
    187. Developments
    188. SWOT Analysis
    189. Key
    190. Strategies
    191. Elanco Animal Health
    192. Financial
    193. Overview
    194. Products Offered
    195. Key
    196. Developments
    197. SWOT Analysis
    198. Key
    199. Strategies
    200. Kemin Industries
    201. Financial
    202. Overview
    203. Products Offered
    204. Key
    205. Developments
    206. SWOT Analysis
    207. Key
    208. Strategies
    209. Merck Animal Health
    210. Financial
    211. Overview
    212. Products Offered
    213. Key
    214. Developments
    215. SWOT Analysis
    216. Key
    217. Strategies
    218. Agrovet
    219. Financial
    220. Overview
    221. Products Offered
    222. Key
    223. Developments
    224. SWOT Analysis
    225. Key
    226. Strategies
    227. Boehringer Ingelheim
    228. Financial
    229. Overview
    230. Products Offered
    231. Key
    232. Developments
    233. SWOT Analysis
    234. Key
    235. Strategies
    236. References
    237. Related
    238. Reports
    239. LIST
    240. OF ASSUMPTIONS
    241. Italy Poultry Vaccines Market SIZE ESTIMATES
    242. & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    243. Italy
    244. Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY SPECIES, 2019-2035 (USD
    245. Billions)
    246. Italy Poultry Vaccines Market SIZE ESTIMATES
    247. & FORECAST, BY ADMINISTRATION ROUTE, 2019-2035 (USD Billions)
    248. Italy
    249. Poultry Vaccines Market SIZE ESTIMATES & FORECAST, BY DISEASE TARGETED, 2019-2035
    250. (USD Billions)
    251. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    252. ACQUISITION/PARTNERSHIP
    253. LIST
    254. Of figures
    255. MARKET SYNOPSIS
    256. ITALY
    257. POULTRY VACCINES MARKET ANALYSIS BY TYPE
    258. ITALY POULTRY
    259. VACCINES MARKET ANALYSIS BY SPECIES
    260. ITALY POULTRY VACCINES
    261. MARKET ANALYSIS BY ADMINISTRATION ROUTE
    262. ITALY POULTRY
    263. VACCINES MARKET ANALYSIS BY DISEASE TARGETED
    264. KEY BUYING
    265. CRITERIA OF POULTRY VACCINES MARKET
    266. RESEARCH PROCESS
    267. OF MRFR
    268. DRO ANALYSIS OF POULTRY VACCINES MARKET
    269. DRIVERS
    270. IMPACT ANALYSIS: POULTRY VACCINES MARKET
    271. RESTRAINTS IMPACT
    272. ANALYSIS: POULTRY VACCINES MARKET
    273. SUPPLY / VALUE CHAIN:
    274. POULTRY VACCINES MARKET
    275. POULTRY VACCINES MARKET, BY TYPE,
    276. (% SHARE)
    277. POULTRY VACCINES MARKET, BY TYPE, 2019
    278. TO 2035 (USD Billions)
    279. POULTRY VACCINES MARKET, BY SPECIES,
    280. (% SHARE)
    281. POULTRY VACCINES MARKET, BY SPECIES, 2019
    282. TO 2035 (USD Billions)
    283. POULTRY VACCINES MARKET, BY ADMINISTRATION
    284. ROUTE, 2025 (% SHARE)
    285. POULTRY VACCINES MARKET, BY ADMINISTRATION
    286. ROUTE, 2019 TO 2035 (USD Billions)
    287. POULTRY VACCINES MARKET,
    288. BY DISEASE TARGETED, 2025 (% SHARE)
    289. POULTRY VACCINES
    290. MARKET, BY DISEASE TARGETED, 2019 TO 2035 (USD Billions)
    291. BENCHMARKING
    292. OF MAJOR COMPETITORS

    Italy Poultry Vaccines Market Segmentation

     

     

     

    • Poultry Vaccines Market By Type (USD Million, 2019-2035)

      • Live Attenuated Vaccines
      • Inactivated Vaccines
      • Subunit Vaccines
      • DNA Vaccines

     

    • Poultry Vaccines Market By Species (USD Million, 2019-2035)

      • Broilers
      • Layers
      • Turkeys
      • Others

     

    • Poultry Vaccines Market By Administration Route (USD Million, 2019-2035)

      • Intramuscular
      • Subcutaneous
      • Oral
      • Inhalation

     

    • Poultry Vaccines Market By Disease Targeted (USD Million, 2019-2035)

      • Newcastle Disease
      • Infectious Bursal Disease
      • Avian Influenza
      • Marek's Disease

     

     

     

     

     

     

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027